Thiazolidinedione derivatives for the treatment of diabetes and other diseases
US6765013B2 · kind B2 · utility
15Cited by
18References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 31, 2002 |
| Grant date | Jul 20, 2004 |
| Priority date | — |
| Expiry date | Dec 31, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.